Literature DB >> 29476592

Chemical Features Important for Activity in a Class of Inhibitors Targeting the Wip1 Flap Subdomain.

Harichandra D Tagad1, Subrata Debnath1, Victor Clausse2, Mrinmoy Saha2, Sharlyn J Mazur1, Ettore Appella1, Daniel H Appella2.   

Abstract

The wild-type p53 induced phosphatase 1, Wip1 (PP2Cδ), is a protein phosphatase 2C (PP2C) family serine/threonine phosphatase that negatively regulates the function of the tumor suppressor p53 and several of its positive regulators such as ATM, Chk1, Chk2, Mdm2, and p38 MAPK. Wip1 dephosphorylates and inactivates its protein targets, which are critical for cellular stress responses. Additionally, Wip1 is frequently amplified and overexpressed in several human cancer types. Because of its negative role in regulating the function of tumor suppressor proteins, Wip1 has been identified as a potential therapeutic target in various types of cancers. Based on a recently reported Wip1 inhibitor (G-1), we performed an extensive structure-activity relationship (SAR) analysis. This led us to interesting findings in SAR trends and to the discovery of new chemical analogues with good specificity and bioavailability.
© 2018 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Keywords:  ELISA; Wip1; enzyme kinetics; inhibitors

Mesh:

Substances:

Year:  2018        PMID: 29476592      PMCID: PMC8022280          DOI: 10.1002/cmdc.201700779

Source DB:  PubMed          Journal:  ChemMedChem        ISSN: 1860-7179            Impact factor:   3.466


  32 in total

1.  Wip1 phosphatase modulates ATM-dependent signaling pathways.

Authors:  Sathyavageeswaran Shreeram; Oleg N Demidov; Weng Kee Hee; Hiroshi Yamaguchi; Nobuyuki Onishi; Calvina Kek; Oleg N Timofeev; Crissy Dudgeon; Albert J Fornace; Carl W Anderson; Yasuhiro Minami; Ettore Appella; Dmitry V Bulavin
Journal:  Mol Cell       Date:  2006-09-01       Impact factor: 17.970

2.  Intrinsic kinase activity and SQ/TQ domain of Chk2 kinase as well as N-terminal domain of Wip1 phosphatase are required for regulation of Chk2 by Wip1.

Authors:  Akinori Yoda; Xiao Zhou Xu; Nobuyuki Onishi; Kyoko Toyoshima; Hiroko Fujimoto; Naoko Kato; Isao Oishi; Takeshi Kondo; Yasuhiro Minami
Journal:  J Biol Chem       Date:  2006-06-23       Impact factor: 5.157

3.  p53-inducible wip1 phosphatase mediates a negative feedback regulation of p38 MAPK-p53 signaling in response to UV radiation.

Authors:  M Takekawa; M Adachi; A Nakahata; I Nakayama; F Itoh; H Tsukuda; Y Taya; K Imai
Journal:  EMBO J       Date:  2000-12-01       Impact factor: 11.598

4.  Genome-wide array-based comparative genomic hybridization analysis of pancreatic adenocarcinoma: identification of genetic indicators that predict patient outcome.

Authors:  Panayiotis Loukopoulos; Tatsuhiro Shibata; Hiroto Katoh; Akiko Kokubu; Michiie Sakamoto; Ken Yamazaki; Tomoo Kosuge; Yae Kanai; Fumie Hosoda; Issei Imoto; Misao Ohki; Jyoji Inazawa; Setsuo Hirohashi
Journal:  Cancer Sci       Date:  2007-01-12       Impact factor: 6.716

5.  Optimization of a cyclic peptide inhibitor of Ser/Thr phosphatase PPM1D (Wip1).

Authors:  Ryo Hayashi; Kan Tanoue; Stewart R Durell; Deb K Chatterjee; Lisa M Miller Jenkins; Daniel H Appella; Ettore Appella
Journal:  Biochemistry       Date:  2011-05-09       Impact factor: 3.162

6.  Development of a substrate-based cyclic phosphopeptide inhibitor of protein phosphatase 2Cdelta, Wip1.

Authors:  Hiroshi Yamaguchi; Stewart R Durell; Hanqiao Feng; Yawen Bai; Carl W Anderson; Ettore Appella
Journal:  Biochemistry       Date:  2006-11-07       Impact factor: 3.162

7.  Wip1 phosphatase is associated with chromatin and dephosphorylates gammaH2AX to promote checkpoint inhibition.

Authors:  L Macůrek; A Lindqvist; O Voets; J Kool; H R Vos; R H Medema
Journal:  Oncogene       Date:  2010-01-25       Impact factor: 9.867

8.  Mosaic PPM1D mutations are associated with predisposition to breast and ovarian cancer.

Authors:  Elise Ruark; Katie Snape; Peter Humburg; Chey Loveday; Ilirjana Bajrami; Rachel Brough; Daniel Nava Rodrigues; Anthony Renwick; Sheila Seal; Emma Ramsay; Silvana Del Vecchio Duarte; Manuel A Rivas; Margaret Warren-Perry; Anna Zachariou; Adriana Campion-Flora; Sandra Hanks; Anne Murray; Naser Ansari Pour; Jenny Douglas; Lorna Gregory; Andrew Rimmer; Neil M Walker; Tsun-Po Yang; Julian W Adlard; Julian Barwell; Jonathan Berg; Angela F Brady; Carole Brewer; Glen Brice; Cyril Chapman; Jackie Cook; Rosemarie Davidson; Alan Donaldson; Fiona Douglas; Diana Eccles; D Gareth Evans; Lynn Greenhalgh; Alex Henderson; Louise Izatt; Ajith Kumar; Fiona Lalloo; Zosia Miedzybrodzka; Patrick J Morrison; Joan Paterson; Mary Porteous; Mark T Rogers; Susan Shanley; Lisa Walker; Martin Gore; Richard Houlston; Matthew A Brown; Mark J Caufield; Panagiotis Deloukas; Mark I McCarthy; John A Todd; Clare Turnbull; Jorge S Reis-Filho; Alan Ashworth; Antonis C Antoniou; Christopher J Lord; Peter Donnelly; Nazneen Rahman
Journal:  Nature       Date:  2012-12-16       Impact factor: 49.962

9.  Medulloblastomas overexpress the p53-inactivating oncogene WIP1/PPM1D.

Authors:  Robert C Castellino; Massimiliano De Bortoli; Xiongbin Lu; Sung-Hwan Moon; Thuy-Ai Nguyen; Mark A Shepard; Pulivarthi H Rao; Lawrence A Donehower; John Y H Kim
Journal:  J Neurooncol       Date:  2007-10-12       Impact factor: 4.130

Review 10.  Wip1 phosphatase: between p53 and MAPK kinases pathways.

Authors:  Anastasia R Goloudina; Elena Y Kochetkova; Tatyana V Pospelova; Oleg N Demidov
Journal:  Oncotarget       Date:  2016-05-24
View more
  3 in total

1.  Clonal hematopoiesis: mechanisms driving dominance of stem cell clones.

Authors:  Grant A Challen; Margaret A Goodell
Journal:  Blood       Date:  2020-10-01       Impact factor: 22.113

2.  Discovery of Novel Small-Molecule Scaffolds for the Inhibition and Activation of WIP1 Phosphatase from a RapidFire Mass Spectrometry High-Throughput Screen.

Authors:  Victor Clausse; Yuhong Fang; Dingyin Tao; Harichandra D Tagad; Hongmao Sun; Yuhong Wang; Surendra Karavadhi; Kelly Lane; Zhen-Dan Shi; Olga Vasalatiy; Christopher A LeClair; Rebecca Eells; Min Shen; Samarjit Patnaik; Ettore Appella; Nathan P Coussens; Matthew D Hall; Daniel H Appella
Journal:  ACS Pharmacol Transl Sci       Date:  2022-09-28

3.  Physiologically relevant orthogonal assays for the discovery of small-molecule modulators of WIP1 phosphatase in high-throughput screens.

Authors:  Victor Clausse; Dingyin Tao; Subrata Debnath; Yuhong Fang; Harichandra D Tagad; Yuhong Wang; Hongmao Sun; Christopher A LeClair; Sharlyn J Mazur; Kelly Lane; Zhen-Dan Shi; Olga Vasalatiy; Rebecca Eells; Lynn K Baker; Mark J Henderson; Martin R Webb; Min Shen; Matthew D Hall; Ettore Appella; Daniel H Appella; Nathan P Coussens
Journal:  J Biol Chem       Date:  2019-09-03       Impact factor: 5.157

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.